TJX Companies Investing Cash Flow decreased by 33.8% to -$673.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.8%, from -$503.00M to -$673.00M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 30.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$224.91M | -$478.10M | -$407.00M | $0.00 | -$324.00M | -$495.00M | -$462.00M | -$189.00M | -$362.00M | -$628.00M | -$617.00M | -$110.00M | -$427.00M | -$542.00M | -$541.00M | -$967.00M | -$503.00M | -$673.00M |
| QoQ Change | — | -112.6% | +14.9% | +100.0% | — | -52.8% | +6.7% | +59.1% | -91.5% | -73.5% | +1.8% | +82.2% | -288.2% | -26.9% | +0.2% | -78.7% | +48.0% | -33.8% |
| YoY Change | — | — | — | — | -44.1% | -3.5% | -13.5% | — | -11.7% | -26.9% | -33.5% | +41.8% | -18.0% | +13.7% | +12.3% | -779.1% | -17.8% | -33.8% |